QR koda

Association of Phenylacetylglutamine and Cognitive Impairment in CKD

Introduction: Chronic kidney disease (CKD) leads to the accumulation of uremic toxins (UTs). Studies have suggested that UTs are associated with cognitive impairment (CI) in patients with CKD. Recently, studies reported that phenylacetylglutamine (PAG) contributes to the association between CKD and...

Popoln opis

Shranjeno v:
Principais autores: Hélène Levassort, Julie Boucquemont, Sophie Liabeuf, Solène M. Laville, Céline Lange, Luc Frimat, Christian Combe, Denis Fouque, Maurice Laville, Christian Jacquelinet, Yves-Edouard Herpe, Islam Amine Larabi, Jean-Claude Alvarez, Natalia Alencar de Pinho, Marion Pépin, Ziad A. Massy, Dorothée Cannet, Aghilès Hamroun, Pascal Morel, Christophe Pascal, Roberto Pecoits-Filho, Joost Schanstra, Bénédicte Stengel, Oriane Lambert, Marie Metzger
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2025-08-01
Serija:Kidney International Reports
Teme:
chronic kidney disease
cognition
phenylacetylglutamine
uremic toxins
Online dostop:http://www.sciencedirect.com/science/article/pii/S2468024925003407
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki